<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(3)</volume><submitter>Okuma Y</submitter><journal>Journal of thoracic disease</journal><pagination>470-473</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5394089</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Osimertinib for advanced non-small cell lung cancer harboring EGFR mutation exon 20 T790M, acquired resistant mutation for first- or second-generation EGFR-TKI.</pubmed_title><pmcid>PMC5394089</pmcid><pubmed_authors>Okuma Y</pubmed_authors><pubmed_authors>Hosomi Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Osimertinib for advanced non-small cell lung cancer harboring EGFR mutation exon 20 T790M, acquired resistant mutation for first- or second-generation EGFR-TKI.</name><description/><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Mar</publication><modification>2025-04-19T17:16:22.111Z</modification><creation>2025-04-19T17:16:22.111Z</creation></dates><accession>S-EPMC5394089</accession><cross_references><pubmed>28449447</pubmed><doi>10.21037/jtd.2017.03.26</doi></cross_references></HashMap>